CREO.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:21):

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom...

Stats
Today's Volume	302 638
Average Volume	805 099
Market Cap	131.04M
EPS	£0 ( 2024-04-23 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-3.30
ATR14	£0.217 (0.59%)

Volume Correlation

Long: 0.17 (neutral)

Short: -0.26 (neutral)

Signal:(53.767) Neutral

Creo Medical Group PLC Correlation

10 Most Positive Correlations
AERI.L	0.824

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Creo Medical Group PLC Correlation - Currency/Commodity

-0.43
( neutral )

-0.53
( weak negative )

0.00
( neutral )

-0.45
( neutral )

0.62
( weak )

0.34
( neutral )

Creo Medical Group PLC Financials

Annual	2022
Revenue:	£27.17M
Gross Profit:	£10.01M (36.84 %)
EPS:	£-0.140

FY	2022
Revenue:	£27.17M
Gross Profit:	£10.01M (36.84 %)
EPS:	£-0.140

FY	2021
Revenue:	£25.16M
Gross Profit:	£11.59M (46.04 %)
EPS:	£-0.158

FY	2020
Revenue:	£9.43M
Gross Profit:	£4.03M (42.79 %)
EPS:	£-0.130

Financial Reports:

No articles found.

Creo Medical Group PLC

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.